CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čes. Radiol., 57, 2003, No. 4, p. 184–191.
 
Effect of Samarium-153-EDTMP Treatment in Patients with Painful Bone Metastases 
Doležal J., Vižďa J., Čermáková E.1, Horáček J.2, Odrážka K.3, Melichar B.3 

Oddělení nukleární medicíny, Fakultní nemocnice, Hradec Králové, přednosta MUDr. ing. J. VižďaOddělení výpočetní techniky, Lékařská fakulta UK, Hradec Králové1 vedoucí prof. MUDr. P. Stránský, CSc. Katedra interních oborů, Lékařská fakulta UK, Hradec Králové2 vedoucí prof. MUDr. J. Malý, CSc. Klinika onkologie a radioterapie, Fakultní nemocnice, Hradec Králové3 přednosta doc. MUDr. J. Petera, PhD.
 


Summary:

       Aim: Bone is a common site of metastatic disease and is the most common site of metastatic spread in breast cancer and prostate cancer.The pain is themost important consequence of bone metastases and is present in most of the patients. Radiotherapy represents one of effective therapeutic options in the palliation of bone pain. Currently, radiation may be delivered either by external irradiation (loco-regional, half-body) or intravenous administration of bone-seeking therapeutic radiopharmaceuticals as is Samarium-153-EDTMP. This radiopharmaceutical produces beta radiation, and is concentrated in areas of enhanced osteoblastic activity.

        Key words: bone pain – bone metastases – Samarium-153-EDTMP
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER